ReviewCureus2023

Guselkumab, a Novel Monoclonal Antibody Inhibitor of the p19 Subunit of IL-23, for Psoriatic Arthritis and Plaque Psoriasis: A Review of Its Mechanism, Use, and Clinical Effectiveness.

Christian K Kerut et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.